SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-20-014372
Filing Date
2020-10-07
Accepted
2020-10-07 17:11:50
Documents
14
Period of Report
2020-10-07
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K xfor-20201007.htm   iXBRL 8-K 48735
  Complete submission text file 0001628280-20-014372.txt   199579

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT xfor-20201007.xsd EX-101.SCH 2423
3 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT xfor-20201007_cal.xml EX-101.CAL 710
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT xfor-20201007_def.xml EX-101.DEF 1643
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT xfor-20201007_lab.xml EX-101.LAB 25998
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT xfor-20201007_pre.xml EX-101.PRE 13731
7 EXTRACTED XBRL INSTANCE DOCUMENT xfor-20201007_htm.xml XML 11812
Mailing Address 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134
Business Address 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134 857-529-8300
X4 Pharmaceuticals, Inc (Filer) CIK: 0001501697 (see all company filings)

IRS No.: 273181608 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38295 | Film No.: 201229620
SIC: 2836 Biological Products, (No Diagnostic Substances)